WestEnd Advisors, LLC has added 25,606 shares of $REGN to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $REGN.
REGENERON PHARMACEUTICALS Hedge Fund Activity
We have seen 681 institutional investors add shares of REGENERON PHARMACEUTICALS stock to their portfolio, and 579 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,231,459 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $1,722,396,258
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,144,887 shares (+142.2%) to their portfolio in Q4 2025, for an estimated $883,703,928
- CAPITAL INTERNATIONAL INVESTORS removed 876,564 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $676,593,454
- NUVEEN, LLC added 835,240 shares (+71.1%) to their portfolio in Q4 2025, for an estimated $644,696,698
- D. E. SHAW & CO., INC. removed 706,118 shares (-82.0%) from their portfolio in Q4 2025, for an estimated $545,031,300
- WELLINGTON MANAGEMENT GROUP LLP added 656,845 shares (+8620.0%) to their portfolio in Q4 2025, for an estimated $506,998,950
- CAPITAL WORLD INVESTORS removed 600,363 shares (-30.0%) from their portfolio in Q4 2025, for an estimated $463,402,188
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
REGENERON PHARMACEUTICALS Insider Trading Activity
REGENERON PHARMACEUTICALS insiders have traded $REGN stock on the open market 44 times in the past 6 months. Of those trades, 0 have been purchases and 44 have been sales.
Here’s a breakdown of recent trading of $REGN stock by insiders over the last 6 months:
- CHRISTINE A POON has made 0 purchases and 6 sales selling 6,500 shares for an estimated $4,252,745.
- JASON PITOFSKY (SVP Controller) has made 0 purchases and 12 sales selling 2,467 shares for an estimated $1,865,824.
- BONNIE L BASSLER has made 0 purchases and 2 sales selling 2,260 shares for an estimated $1,770,000.
- HUDA Y ZOGHBI has made 0 purchases and 11 sales selling 1,638 shares for an estimated $1,279,811.
- ARTHUR F RYAN has made 0 purchases and 13 sales selling 100 shares for an estimated $77,852.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
REGENERON PHARMACEUTICALS Congressional Stock Trading
Members of Congress have traded $REGN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $REGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/12.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
REGENERON PHARMACEUTICALS Analyst Ratings
Wall Street analysts have issued reports on $REGN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 02/02/2026
- Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026
- B of A Securities issued a "Buy" rating on 01/07/2026
- BMO Capital issued a "Outperform" rating on 12/04/2025
- HSBC issued a "Buy" rating on 11/24/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
To track analyst ratings and price targets for REGENERON PHARMACEUTICALS, check out Quiver Quantitative's $REGN forecast page.
REGENERON PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $REGN recently. We have seen 19 analysts offer price targets for $REGN in the last 6 months, with a median target of $860.0.
Here are some recent targets:
- Matthew Harrison from Morgan Stanley set a target price of $796.0 on 04/10/2026
- William Pickering from Bernstein set a target price of $921.0 on 04/08/2026
- Biren Amin from Piper Sandler set a target price of $875.0 on 03/31/2026
- Gregory Renza from Truist Securities set a target price of $801.0 on 03/31/2026
- Eliana Merle from Barclays set a target price of $923.0 on 03/06/2026
- Brian Abrahams from RBC Capital set a target price of $765.0 on 03/02/2026
- Yatin Suneja from Guggenheim set a target price of $975.0 on 02/09/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $REGN ticker page for more data.
